Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Photodiagnosis Photodyn Ther ; 31: 101919, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32679192

ABSTRACT

Opportunistic infections in the oral cavity can cause serious complications in immunocompromised cancer patients. Efficient treatments options are essential. This article reports two clinical cases of adolescent patients diagnosed with leukemia, who presented with infectious conditions in the oral cavity. Antimicrobial photodynamic therapy was used as an adjuvant therapy to abbreviate the course of these oral lesions.


Subject(s)
Antineoplastic Agents , Leukemia , Photochemotherapy , Adolescent , Humans , Leukemia/drug therapy , Mouth , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use
2.
Spec Care Dentist ; 38(2): 95-98, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29509314

ABSTRACT

AIM: To report a case of a pediatric patient carrier of myelodysplastic syndrome (MDS) with severe oral infectious disease, in which antimicrobial photodynamic therapy (aPDT) was used as a therapeutic choice to support systemic treatment. METHODS AND RESULTS: This case report refers to a 1-year-old male patient with MDS and hospitalized for investigation and treatment of complications at a Pediatric Oncology and Hematology Center in Recife/PE, Brazil. The intraoral examination revealed a violaceous lesion surrounding the lower incisor teeth, which progressed with alteration of color to milky yellowish white, compromising the entire lower gingival border, leading to tooth mobility and consequent loss of teeth 71 and 81. The patient was treated under systemic antimicrobial therapy and aPDT was also performed, using a photosensitizing agent (methylene blue, 0.01%) and a low-intensity laser in the visible red spectrum. Oral clinical improvement was observed, but the patient died after 45 days of hospitalization in the Pediatric ICU due to other systemic complications. CONCLUSION: MDS may present limiting oral repercussions interfering in patients' quality of life. The aPDT is presented as an adjuvant therapeutic modality in oral infections with satisfactory results.


Subject(s)
Bacterial Infections/drug therapy , Bacterial Infections/microbiology , Gingival Diseases/drug therapy , Gingival Diseases/microbiology , Methylene Blue/therapeutic use , Myelodysplastic Syndromes/complications , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use , Anti-Bacterial Agents/therapeutic use , Fatal Outcome , Humans , Infant , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...